Literature DB >> 31445020

Microglia-neuron interactions in the models of neuropathic pain.

Hidetoshi Tozaki-Saitoh1, Makoto Tsuda2.   

Abstract

Chronic pain is a debilitating condition that often emerges as a clinical symptom of inflammatory diseases. It has therefore been widely accepted that the immune system critically contributes to the pathology of chronic pain. Microglia, a type of immune cell in the central nervous system, has attracted researchers' attention because in rodent models of neuropathic pain that develop strong mechanical and thermal hypersensitivity, histologically activated microglia are seen in the dorsal horn of spinal cord. Several kinds of cytokines are generated by damaged peripheral neurons and contribute to microglial activation at the distal site of the injury where damaged neurons send their projections. Microglia are known as key players in the surveillance of the local environment in the central nervous system and have a significant role of circuit remodeling by physical contact to synapses. Key molecules for the pathology of neuropathic pain exist in the activated microglia, but the factors driving pain-inducible microglial activation remain unclear. Therefore, to find the key molecules inducing activation of spinal microglia and to figure out the precise mechanism of how microglia modulate neuronal circuits in the spinal cord to form chronic pain state is a critical step for developing effective treatment of neuropathic pain.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CSF1; Chemokine; Microglia; Neuropathic pain; Purinergic receptor

Mesh:

Substances:

Year:  2019        PMID: 31445020     DOI: 10.1016/j.bcp.2019.08.016

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  15 in total

Review 1.  The role of microglia in chronic pain and depression: innocent bystander or culprit?

Authors:  Nan Yin; Enshi Yan; Wenbin Duan; Changyuan Mao; Qin Fei; Chun Yang; Yimin Hu; Xiaolin Xu
Journal:  Psychopharmacology (Berl)       Date:  2021-02-05       Impact factor: 4.530

Review 2.  Histamine and Microglia.

Authors:  Tomomitsu Iida; Kazuhiko Yanai; Takeo Yoshikawa
Journal:  Curr Top Behav Neurosci       Date:  2022

3.  The Programmed Cell Death Ligand-1/Programmed Cell Death-1 Pathway Mediates Pregnancy-Induced Analgesia via Regulating Spinal Inflammatory Cytokines.

Authors:  HuiLing Tan; ZhenDong Ding; ChengLiang Zhang; JianQin Yan; Yong Yang; Ping Li
Journal:  Anesth Analg       Date:  2021-11-01       Impact factor: 6.627

Review 4.  Physiology and Pathophysiology of Itch.

Authors:  Ferda Cevikbas; Ethan A Lerner
Journal:  Physiol Rev       Date:  2019-12-23       Impact factor: 37.312

5.  Neuropeptide Y in the amygdala contributes to neuropathic pain-like behaviors in rats via the neuropeptide Y receptor type 2/mitogen-activated protein kinase axis.

Authors:  Wenhui Yan; Wuchao Liu; Junlu Wu; Lipei Wu; Shihai Xuan; Weiwei Wang; Anquan Shang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

6.  DOK3 is involved in microglial cell activation in neuropathic pain by interacting with GPR84.

Authors:  Wen-Shuang Gao; Yu-Juan Qu; Juan Huai; Hui Wei; Yang Zhang; Shou-Wei Yue
Journal:  Aging (Albany NY)       Date:  2020-12-03       Impact factor: 5.682

Review 7.  Differential Expression of Long Non-Coding RNAs and Their Role in Rodent Neuropathic Pain Models.

Authors:  Songchao Xu; He Dong; Yang Zhao; Wei Feng
Journal:  J Pain Res       Date:  2021-12-30       Impact factor: 3.133

8.  Circular RNA SMEK1 promotes neuropathic pain in rats through targeting microRNA-216a-5p to mediate Thioredoxin Interacting Protein (TXNIP) expression.

Authors:  Yufu Xin; Xinrong Song; Qingye Ge
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 9.  Chronic Pain After Spinal Cord Injury: Is There a Role for Neuron-Immune Dysregulation?

Authors:  Sílvia S Chambel; Isaura Tavares; Célia D Cruz
Journal:  Front Physiol       Date:  2020-07-07       Impact factor: 4.566

Review 10.  Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth.

Authors:  Heath McAnally; Udo Bonnet; Alan D Kaye
Journal:  Pain Ther       Date:  2020-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.